47 results on '"Noto, Cristiano"'
Search Results
2. T100. DIFFERENTIAL EXPRESSION OF SERUM EXOSOME MIRNA IN DRUG-NAIVE FIRST PSYCHOSIS EPISODE PATIENTS FOLLOWED BY RISPERIDONE TREATMENT
3. METHYLATION MARKERS IN A COHORT OF FIRST-EPISODE PSYCHOSIS PATIENTS TREATED WITH RISPERIDONE
4. Differences of affective and non-affective psychoses in early intervention services from Latin America
5. Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging
6. COVID-19 contamination and severity among patients with schizophrenia: Results from a specialized outpatient clinic survey
7. Aging biological markers in a cohort of antipsychotic-naïve first-episode psychosis patients
8. W70. SMALL RNA EXPRESSION PROFILE FROM EXOSOMES OF FIRST EPISODE PSYCHOSIS PATIENTS
9. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system
10. Clozapine-induced hepatotoxicity: A life threatening situation
11. Esketamine for Postpartum Suicidality
12. Blood gene expression changes after Risperidone treatment in an antipsychotic-naïve cohort of first episode of psychosis patients
13. A symptom combination predicting treatment-resistant schizophrenia – A strategy for real-world clinical practice
14. Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia
15. Cannabis acute use impacts symptoms and functionality in a cohort of antipsychotic naïve First Episode of Psychosis individuals
16. DGCR2 influences cortical thickness through a mechanism independent of schizophrenia pathogenesis
17. Corrigendum to “Oxidative and nitrosative stress biomarkers in chronic schizophrenia”
18. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis
19. INVESTIGATION OF THE RISPERIDONE TREATMENT RESPONSE: A PHARMACOGENETICS STUDY IN A COHORT OF FIRST EPISODE OF PSYCHOSIS PATIENTS
20. F131EVALUATION OF EXTRACELLULAR VESICLES MIRNA DIFFERENTIAL EXPRESSION AMONG FIRST EPISODE PSYCHOSIS
21. INDICATION OF CELL AGING BASED ON DNAMETHYLATION IN EARLY STAGE OF SCHIZOPHRENIA
22. GENOME-WIDE DNA METHYLATION ANALYSIS IN A LONGITUDINAL COHORT OF ANTIPSYCHOTIC-NAIVE FIRST EPISODE OF PSYCHOSIS PATIENTS
23. LINE-1 HYPOMETHYLATION MIGHT BE RELATED TO A POOR RESPONSE TO TREATMENT
24. F123GENETIC INVESTIGATION OF RISPERIDONE TREATMENT RESPONSE IN A BRAZILIAN COHORT OF FIRST EPISODE OF PSYCHOSIS
25. POLYGENIC RISK SCORE ANALYSES OF SYMPTOMS AND TREATMENT RESPONSE IN A FIRST EPISODE SCHIZOPHRENIA COHORT
26. Investigating brain structural patterns in first episode psychosis and schizophrenia using MRI and a machine learning approach
27. Leukocyte telomere length variation in different stages of schizophrenia
28. Oxidative and nitrosative stress biomarkers in chronic schizophrenia
29. Shorter leukocyte telomere length in patients at ultra high risk for psychosis
30. New evidence in support of staging approaches in schizophrenia: Differences in clinical profiles between first episode, early stage, and late stage
31. Gene Expression Alterations Related To Mania And Psychotic Symptoms In Peripheral Blood of Patients with A First Episode of Psychosis
32. The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
33. Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis
34. Structural covariance in schizophrenia and first-episode psychosis: An approach based on graph analysis
35. Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia
36. Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls
37. Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone
38. Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis
39. Effects of depression on the cytokine profile in drug naïve first-episode psychosis
40. Changes in gene expression and methylation in the blood of patients with first-episode psychosis
41. What are the PANSS items most related with global improvements in patients with schizophrenia? Toward a reduced version of the PANSS
42. Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: A follow-up study in antipsychotic-naïve patients with first-episode psychosis
43. Poster #S144 NEURODEVELOPMENT GENES ARE DIFFERENTIALLY EXPRESSED IN BLOOD OF SUBJECTS AT ULTRA HIGH RISK (UHR) TO PSYCHOSIS COMPARED TO CONTROLS AND FIRST EPISODE OF PSYCHOSIS (FEP) PATIENTS
44. Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naïve first-episode psychosis patients before and after antipsychotic treatment
45. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia
46. Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia
47. Association of biomarkers and depressive symptoms in schizophrenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.